AlanSubie4Life
Efficiency Obsessed Member
Look at the percentage that had a measurable titer though after a boost (two weeks post boost). 78%! Quite a bit better than what we see against delta after just two doses and six months (50%). And way way better than those other combinations.Obviously, more time needs to pass to know more about full spectrum of lab studies and clinical manifestations of omicron’s effect on vaccines.
Here’s the in-vitro results from a study out of Germany (similar to what was done in SA).
That drop.
So it is going to kind of depend on how the boost wanes, exactly. If the titers generally stay high, then we may see better results than we did with Delta after six months.
But clearly a challenge, and I think we’ll definitely see an efficacy drop off for boosted people, but hard to know how much (75%?). Vulnerable triple-vaccinated individuals will need to be careful or at least figure out their neutralizing antibody levels (tricky/impossible).
We still need to see how it can outcompete delta (unclear but I would guess it will) and how intrinsically severe it is.
And we need to know the protection level afforded by t-cells in triple-vaccinated individuals if they get a breakthrough. Will it be 50% efficacy against hospitalization? Or 90%?